These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35114189)

  • 1. Nigericin exerts anticancer effects through inhibition of the SRC/STAT3/BCL-2 in osteosarcoma.
    Yang Z; Xie J; Fang J; Lv M; Yang M; Deng Z; Xie Y; Cai L
    Biochem Pharmacol; 2022 Apr; 198():114938. PubMed ID: 35114189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigericin Exerts Anticancer Effects on Human Colorectal Cancer Cells by Inhibiting Wnt/β-catenin Signaling Pathway.
    Liu F; Li W; Hua S; Han Y; Xu Z; Wan D; Wang Y; Chen W; Kuang Y; Shi J; Zhi Q
    Mol Cancer Ther; 2018 May; 17(5):952-965. PubMed ID: 29483216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
    Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
    BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway.
    Huang L; Huang Z; Lin W; Wang L; Zhu X; Chen X; Yang S; Lv C
    Int J Oncol; 2019 Jun; 54(6):1969-1980. PubMed ID: 31081055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway.
    Park KR; Yun HM; Hong JT
    Int J Biol Sci; 2020; 16(2):330-341. PubMed ID: 31929760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T52 attenuates oncogenic STAT3 signaling and suppresses osteosarcoma.
    Tian L; Li C; Xiang L; Zeng J; Chen S; Guo W; Chen S; Wang Y; He X; Su P; Xu C
    Phytomedicine; 2023 Jun; 114():154799. PubMed ID: 37058945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein.
    Kotha A; Sekharam M; Cilenti L; Siddiquee K; Khaled A; Zervos AS; Carter B; Turkson J; Jove R
    Mol Cancer Ther; 2006 Mar; 5(3):621-9. PubMed ID: 16546976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
    Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma.
    Liu K; Ren T; Huang Y; Sun K; Bao X; Wang S; Zheng B; Guo W
    Cell Death Dis; 2017 Aug; 8(8):e3015. PubMed ID: 28837148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgetin exerts growth inhibitory and apoptotic effects on osteosarcoma cells through inhibition of STAT3 and activation of caspase-3/9.
    Xiong M; Wang L; Yu HL; Han H; Mao D; Chen J; Zeng Y; He N; Liu ZG; Wang ZY; Xu SJ; Guo LY; Wang YA
    Oncol Rep; 2016 Feb; 35(2):1034-40. PubMed ID: 26573608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
    Mao M; Zhang T; Wang Z; Wang H; Xu J; Yin F; Wang G; Sun M; Wang Z; Hua Y; Cai Z
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1214-1225. PubMed ID: 30659925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knocking down Siglec-15 in osteosarcoma cells inhibits proliferation while promoting apoptosis and pyroptosis by targeting the Siglec-15/STAT3/Bcl-2 pathway.
    Song K; Ma J; Gao Y; Qu Y; Ren C; Yan P; Zheng B; Yue B
    Adv Med Sci; 2022 Sep; 67(2):187-195. PubMed ID: 35398779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.
    Zhang S; Wang Y; Chen S; Li J
    Biomed Pharmacother; 2018 Oct; 106():1396-1403. PubMed ID: 30119212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
    Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
    Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3/c-Myc signaling pathway in human osteosarcoma cells.
    Ning R; Chen G; Fang R; Zhang Y; Zhao W; Qian F
    Biol Res; 2021 Dec; 54(1):40. PubMed ID: 34922636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
    Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
    BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis.
    Wang L; Xue GB
    Biochem Biophys Res Commun; 2018 Jan; 495(1):27-34. PubMed ID: 29032182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
    Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
    J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.